inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
Published 9 months ago • 133 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
2:44
phase ii trial of obinutuzumab, alone and combined with vemurafenib, in r/r hairy cell leukemia
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:39
phase i/ii trial of adct-602 in b-all
-
1:07
final results of a phase ii study of add-on parsaclisib for pts with mf and suboptimal rux response
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
1:17
phase ii study of tosedostat in mds
-
1:45
a phase ii study of elritercept for lower-risk mds
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:20
phase ii study investigating the efficacy of daratumumab in patients with stage 3b al amyloidosis
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
1:44
insights into the phase ii tidal study
-
4:06
a phase ii trial of intermittent treatment strategies for ndmm to avoid asct
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
1:04
phase i/ii study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with cml
-
2:59
phase ii study update of tl-895 in patients with myelofibrosis with severe thrombocytopenia
-
1:37
a phase i/ii trial of seclidemstat in combination with azacitidine for patients with mds and cmml
-
3:40
master class in transplantation and hematology: highlights
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv